References
- Jones LC, Kaste SC, Karol SE, et al. Team approach: Management of
osteonecrosis in children with acute lymphoblastic leukemia
[published online ahead of print, 2020 Aug 29]. Pediatr Blood
Cancer. 2020;e28509. doi:10.1002/pbc.28509
- Mattano LA Jr, Devidas M, Nachman JB, et al. Effect of alternate-week
versus continuous dexamethasone scheduling on the risk of
osteonecrosis in paediatric patients with acute lymphoblastic
leukaemia: results from the CCG-1961 randomised cohort trial. Lancet
Oncol. 2012;13(9):906‐915. doi:10.1016/S1470-2045(12)70274-7
- Won AM, Boddu P, Otun AO, Aponte-Wesson R, Chambers M. Chronic
myelogenous leukemia presenting with osteonecrosis of the jaw as a
rare but debilitating toxicity of dasatinib: a case report and
literature review. Oral Surg Oral Med Oral Pathol Oral Radiol.
2018;126(4):e208‐e211. doi:10.1016/j.oooo.2018.05.008
- Yassin MA, Moustafa AH, Nashwan AJ, et al. Dasatinib Induced Avascular
Necrosis of Femoral Head in Adult Patient with Chronic Myeloid
Leukemia. Clin Med Insights Blood Disord. 2015;8:19‐23. Published 2015
Jul 23. doi:10.4137/CMBD.S24628